Home › Chronic Kidney Disease › Connecticut
Chronic Kidney Disease clinical trials in Connecticut
8 studies for Chronic Kidney Disease are looking for participants at sites in Connecticut.
Cities in Connecticut
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, New Britain
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06742723Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Yale University, New Haven
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 11, 2026 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Hartford
- Research Site, Middlebury
- Research Site, Waterbury
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07753993Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
Recruiting
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT05465044Study of BHV-1400 in IgA Nephropathy
- Site-001, Farmington
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Kidney Precision Medicine Project
- Yale University, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 14, 2026 · NCT04334707Transformative Research in Diabetic Nephropathy
- Yale University, New Haven
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Feb 27, 2026 · NCT02986984A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
- PACT Kidney Care - Orange, Orange
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Jan 29, 2026 · NCT06933472From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.